Established in December 1993, Medicamen Group has vertically integrated facilities in terms of R&D, APIs & Formulations.
The company is now focusing on oncology therapeutics & other generics with a vision to be a Global Leader in Oncology generics by offering affordable medicine with best-in-class quality.
Apart from the above, a set of 10 Non-oncology formulations is also being determined in R & D for EU market filings. The company has firm plans & investments for Global rollout of its oncology Products in USA, Europe, Latin America, Asia-Pacific, MENA etc. through a combination of own team & alliance partners.
Medicamen follows innovative business models to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Medicamen Biotech.
RAHUL BISHNOI Chairman, Medicamen Biotech
Committed to transform life of people through quality and innovative healthcare solutions and making it accessible to more people.
We maintain stringent control systems and procedures to ensure compliance with CGMP standards.
Make courageous choices for agile transformation, with the aim to drive efficiency, effectiveness and growth
Transforming solution We strive constantly towards developing Transforming solutions in all aspects of our service. We think proactively.
Trusted Partner We build relations that enable us to deliver lasting solutions for the benefit of our customers. We are proud to be trusted by our customers and suppliers world over.